AmacaThera is a company headquartered in Canada.
AmacaThera develops a tunable injectable hydrogel drug delivery platform designed for precise, localized, and sustained release of therapeutics to improve patient outcomes across multiple areas, including post-surgical pain and cancer treatment.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.